Quaker Chemical Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on October 29, 2026, reporting third-quarter net sales of $544,548 thousand and nine-month net income attributable to the company of $76,481 thousand.

Key Highlights

  • Third-quarter net sales: $544,548 thousand for the three months ended September 30, 2026, compared with $493,842 thousand in the same period of 2025.
  • Third-quarter net income attributable to Quaker Chemical: $29,977 thousand, versus $30,469 thousand in Q3 2025.
  • Diluted EPS (Q3 2026): $1.73 per share, compared with $1.75 per share in Q3 2025.
  • Nine-month net income swing: Net income attributable to the company was $76,481 thousand for the nine months ended September 30, 2026, compared with a net loss of $23,189 thousand for the same period of 2025, which included $88,840 thousand in impairment charges.
  • Total assets: $2,915,332 thousand as of September 30, 2026, up from $2,797,936 thousand at December 31, 2025.
  • Shares outstanding: 17,191,961 shares of common stock outstanding as of October 26, 2026.
  • Dividends declared: $0.530 per share for Q3 2026, compared with $0.508 per share in Q3 2025.

Quaker Chemical's Third-Quarter 2026 Financial Results and Balance Sheet Position

According to the filing, Quaker Chemical Corporation (NYSE:KWR) reported net sales of $544,548 thousand for the three months ended September 30, 2026, an increase from $493,842 thousand in the corresponding prior-year quarter. Gross profit for the quarter was $193,523 thousand, up from $180,865 thousand in Q3 2025. Selling, general and administrative expenses rose to $136,407 thousand from $126,479 thousand. Restructuring and related charges, net, were $8,263 thousand for the quarter, the filing disclosed. Operating income came in at $48,853 thousand for Q3 2026, compared with $46,641 thousand a year earlier.

For the nine months ended September 30, 2026, the company reported net sales of $1,557,577 thousand versus $1,420,156 thousand for the same period of 2025, according to the filing. Operating income for the nine-month period was $123,045 thousand, compared with $21,755 thousand in the prior-year period, which included impairment charges of $88,840 thousand that were not repeated in 2026. Diluted earnings per share for the nine months ended September 30, 2026 were $4.40, compared with a loss of $1.32 per share in the comparable 2025 period.

The condensed consolidated balance sheet as of September 30, 2026 showed total assets of $2,915,332 thousand and total equity of $1,417,082 thousand, the filing reported. Long-term debt stood at $871,462 thousand, up from $834,901 thousand at December 31, 2025. Cash and cash equivalents were $167,006 thousand at September 30, 2026, compared with $179,829 thousand at year-end 2025. Common stock had an authorized limit of 30,000,000 shares, with 17,191,225 shares issued and outstanding at September 30, 2026, down from 17,331,779 shares at December 31, 2025, according to the filing.

What Was Disclosed

Quaker Chemical Corporation filed its unaudited quarterly report for the period ended September 30, 2026, disclosing income statement, balance sheet, and cash flow data reflecting higher net sales year-over-year and a return to profitability for the nine-month period relative to the prior year.